Sanford-Burnham researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment:

Sanford-Burnham researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment:   NCI Cancer Center News Researchers at Sanford-Burnham Medical Research Institute are developing techniques to deliver cancer drugs directly to tumors, increasing their effectiveness and decreasing collateral damage. In a study published the week of November 21 in the Proceedings of … Continue reading “Sanford-Burnham researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment:”

Sanford-Burnham researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment:

 

NCI Cancer Center News

Researchers at Sanford-Burnham Medical Research Institute are developing techniques to deliver cancer drugs directly to tumors, increasing their effectiveness and decreasing collateral damage. In a study published the week of November 21 in the Proceedings of the National Academy of Sciences of the USA, a team coupled a cancer drug to a small protein called IF7, which is specifically attracted to the blood vessels that feed tumors. When administered in a mouse model of human colon cancer, IF7 carried the drug directly to tumors, where it suppressed growth at low dosages and with no apparent side effects. These findings suggest that IF7 is an efficient drug delivery vehicle that could be further exploited to target a variety of anti-cancer therapeutics where they’re needed most, without harming other tissues.

Click here to read full press release from Sanford-Burnham Medical Research Institute.

###

NCI cancer centers logoAmong the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply

Sanford-Burnham researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment:

Sanford-Burnham researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment:

 

NCI Cancer Center News

Researchers at Sanford-Burnham Medical Research Institute are developing techniques to deliver cancer drugs directly to tumors, increasing their effectiveness and decreasing collateral damage. In a study published the week of November 21 in the Proceedings of the National Academy of Sciences of the USA, a team coupled a cancer drug to a small protein called IF7, which is specifically attracted to the blood vessels that feed tumors. When administered in a mouse model of human colon cancer, IF7 carried the drug directly to tumors, where it suppressed growth at low dosages and with no apparent side effects. These findings suggest that IF7 is an efficient drug delivery vehicle that could be further exploited to target a variety of anti-cancer therapeutics where they’re needed most, without harming other tissues.

Click here to read full press release from Sanford-Burnham Medical Research Institute.

###

NCI cancer centers logoAmong the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply